Skip to main content

Ionis to present at upcoming investor conferences

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

  • 24th Annual Needham Virtual Healthcare Conference on Monday, April 7, 2025
  • Bank of America 2025 Health Care Conference on Wednesday, May 14, 2025
  • 2025 RBC Capital Markets Global Healthcare Conference on Wednesday, May 21, 2025

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has six marketed medicines and a leading pipeline in neurology, cardiology and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter), LinkedIn and Instagram.

Contacts

Ionis Pharmaceuticals Investor Contact:

D. Wade Walke, Ph.D. – ir@ionis.com760-603-2331



Ionis Pharmaceuticals Media Contact:

Hayley Soffer – media@ionis.com – 760-603-4679

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.33
-0.21 (-0.09%)
AAPL  272.39
-1.72 (-0.63%)
AMD  207.53
-0.05 (-0.02%)
BAC  55.22
-0.11 (-0.20%)
GOOG  307.75
-1.56 (-0.51%)
META  648.44
+0.93 (0.14%)
MSFT  471.91
-2.91 (-0.61%)
NVDA  175.38
-0.91 (-0.52%)
ORCL  186.25
+1.33 (0.72%)
TSLA  471.57
-3.74 (-0.79%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.